BTMD
biote Corp.
NASDAQ · Healthcare · Medical - Care Facilities · US
$1.36
+0.74%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.05
- Revenue estimate
- $44.0M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.23
- EPS estimate
- $0.03
- Revenue actual
- $44.2M
- Revenue estimate
- $46.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -151.4%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $1.75
- PT range
- $1.50 – $2.00
- Analysts
- 2
1 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | $0.03 | -$0.23 | Miss -962.39% | $44.2M |
| May 6, 2026 | $0.09 | $0.06 | Miss -33.33% | $44.9M |
| Mar 11, 2026 | $0.04 | $0.06 | Beat 50.00% | $46.4M |
| Nov 5, 2025 | $0.05 | $0.22 | Beat 340.00% | $48.0M |
| Mar 12, 2025 | $0.09 | $0.10 | Beat 11.11% | $49.8M |
| Aug 8, 2024 | $0.09 | $0.14 | Beat 55.56% | $49.2M |
| Mar 12, 2024 | $0.08 | $0.18 | Beat 125.00% | $45.7M |
| Aug 10, 2023 | $0.10 | $0.44 | Beat 340.00% | $49.3M |
| Nov 14, 2022 | $0.14 | -$0.09 | Miss -164.29% | $42.0M |
| Aug 15, 2022 | $0.14 | $0.27 | Beat 92.86% | $41.4M |
| May 20, 2022 | — | $1.23 | — | $37.1M |
| Nov 24, 2021 | — | $1.13 | — | $35.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026